0 (0%) | 06-28 18:07 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 17.12 | 1-year : | 18.1 |
Resists | First : | 14.65 | Second : | 15.5 |
Pivot price | 14.53 | |||
Supports | First : | 13.3 | Second : | 11.06 |
MAs | MA(5) : | 13.89 | MA(20) : | 14.62 |
MA(100) : | 12.34 | MA(250) : | 9.67 | |
MACD | MACD : | -0.2 | Signal : | 0 |
%K %D | K(14,3) : | 12.6 | D(3) : | 16.5 |
RSI | RSI(14): 41.2 | |||
52-week | High : | 18.56 | Low : | 5.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IPX ] has closed above bottom band by 21.5%. Bollinger Bands are 12.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 13.89 - 13.96 | 13.96 - 14.02 |
Low: | 13.46 - 13.53 | 13.53 - 13.6 |
Close: | 13.76 - 13.88 | 13.88 - 13.99 |
Thu, 18 Apr 2024
Impax Laboratories Inc. (IPXL) in Focus: Stock Rises 11.8% - Yahoo Canada Shine On
Mon, 18 Dec 2017
Robert Stewart to Join Amneal Pharmaceuticals as President - Markets Insider
Wed, 18 Oct 2017
Impax Laboratories Announces Leadership Transition - PR Newswire
Tue, 17 Oct 2017
Amneal And Impax To Combine USA - English - India - English - PR Newswire
Fri, 01 Sep 2017
Impax Laboratories, Inc. (IPXL) in Focus: Stock Moves 20.6% Higher - Yahoo Movies Canada
Thu, 22 Dec 2016
Impax labs gives Buchi interim-CEO job - Philadelphia - The Business Journals
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 23 (M) |
Shares Float | 176 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 8.8 (%) |
Shares Short | 33 (K) |
Shares Short P.Month | 29 (K) |
EPS | -0.94 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.14 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -45.9 % |
Return on Equity (ttm) | -84.3 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.83 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -16 (M) |
Levered Free Cash Flow | -21 (M) |
PE Ratio | -14.77 |
PEG Ratio | 0 |
Price to Book value | 99.14 |
Price to Sales | 0 |
Price to Cash Flow | -19.42 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |